Form 4 for BIO BIO-RAD LABORATORIES, INC.
Accepted 2023-09-06 00:00:00 ET · period of report 2023-09-01 · accession 0001062993-23-017654 · SEC index · Original document
Summary rows
Aggregated the way they appear in lists: one row per insider, transaction code and security table.
| X | Filed | Traded | Ticker | Insider | Title | Type | Price | Qty | Owned | ΔOwn | Value |
|---|---|---|---|---|---|---|---|---|---|---|---|
| DM | 2023-09-06 | 2023-09-01+ | BIO | Last Andrew J. | EVP, COO | F - Tax | $394.60 | -1,157 | 4,585 | -20% | -$456.6K |
| DM | 2023-09-06 | 2023-09-01+ | BIO | Last Andrew J. | EVP, COO | M - OptEx | $0.00 | +2,403 | 5,488 | +78% | $0 |
| D | 2023-09-06 | 2023-09-01 | BIO | Last Andrew J. | EVP, COO | A - Grant | $0.00 | +5,008 | 5,008 | New | $0 |
| DM | 2023-09-06 | 2023-09-01+ | BIO | Last Andrew J. | EVP, COO | M - OptEx | $0.00 | -2,403 | 2,602 | -48% | $0 |
Purchase Sale Sale after option exercise All abbreviations
Every reported transaction
| # | Table | Security | Date | Code | A/D | Shares | Price | Owned after | Own | Exercise / expiry | Underlying | Footnotes |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| 1 | Common | Bio-Rad A Common Stock | 2023-09-02 | F | D | 448 | $394.60 | 5,039.60 | D | — | — | |
| 2 | Common | Bio-Rad A Common Stock | 2023-09-01 | M | A | 633 | $0.00 | 4,863.60 | D | — | — | (F1) Shares of Class A common stock acquired on the vesting of restricted stock units. |
| 3 | Common | Bio-Rad A Common Stock | 2023-09-01 | M | A | 867 | $0.00 | 4,660.60 | D | — | — | (F1) Shares of Class A common stock acquired on the vesting of restricted stock units. (F2) Includes 26.9850 shares acquired under the Bio-Rad Employee Stock Purchase Plan on 06/30/2023. |
| 4 | Common | Bio-Rad A Common Stock | 2023-09-01 | F | D | 430 | $394.60 | 4,230.60 | D | — | — | |
| 5 | Common | Bio-Rad A Common Stock | 2023-09-01 | F | D | 279 | $394.60 | 4,584.60 | D | — | — | |
| 6 | Common | Bio-Rad A Common Stock | 2023-09-02 | M | A | 903 | $0.00 | 5,487.60 | D | — | — | (F1) Shares of Class A common stock acquired on the vesting of restricted stock units. |
| 7 | Derivative | Restricted Stock Units | 2023-09-01 | A | A | 5,008 | $0.00 | 5,008 | D | $0.00 · — to — | 5,008 Bio-Rad A Common Stock | (F3) Each restricted stock unit represents a contingent right to receive one share of Bio-Rad Class A common stock. (F4) The restricted stock units vest over four years at 25% per year on the yearly anniversary date of the grant. |
| 8 | Derivative | Restricted Stock Units | 2023-09-02 | M | D | 903 | $0.00 | 903 | D | $0.00 · — to — | 903 Bio-Rad A Common Stock | (F3) Each restricted stock unit represents a contingent right to receive one share of Bio-Rad Class A common stock. (F7) On September 2, 2020, the reporting person was granted 3,610 restricted stock units, vesting in four equal annual installments beginning on the first anniversary of the grant date. |
| 9 | Derivative | Restricted Stock Units | 2023-09-01 | M | D | 633 | $0.00 | 1,266 | D | $0.00 · — to — | 633 Bio-Rad A Common Stock | (F3) Each restricted stock unit represents a contingent right to receive one share of Bio-Rad Class A common stock. (F6) On September 1, 2021, the reporting person was granted 2,532 restricted stock units, vesting in four equal annual installments beginning on the first anniversary of the grant date. |
| 10 | Derivative | Restricted Stock Units | 2023-09-01 | M | D | 867 | $0.00 | 2,602 | D | $0.00 · — to — | 867 Bio-Rad A Common Stock | (F3) Each restricted stock unit represents a contingent right to receive one share of Bio-Rad Class A common stock. (F5) On September 1, 2022, the reporting person was granted 3,469 restricted stock units, vesting in four equal annual installments beginning on the first anniversary of the grant date. |